Skip to main content
Top

Drugs

Issue 1/2026

Content (11 Articles)

Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies

Caterina Vaghi, Federica Tosi, Gianluca Mauri, Erica Bonazzina, Alessio Amatu, Katia Bencardino, Daniele Piscazzi, Laura Roazzi, Federica Villa, Michelangelo Maggi, Letizia Monti, Anna Bombelli, Giovanna Marrapese, Silvia Ghezzi, Giorgio Patelli, Javier Ros, Elena Elez, Andrea Sartore-Bianchi, Salvatore Siena

Pan-JAK Inhibition Across Chronic Hand Eczema and Other Cutaneous Diseases: An Updated Review on Topical Delgocitinib

Davide Termini, Gianluca Avallone, Gianluca Tavoletti, Jessica Beaziz, Chiara Moltrasio, Veronica Boero, Angelo Valerio Marzano, Silvia Mariel Ferrucci

Sepiapterin: First Approval

Yvette N. Lamb

Dordaviprone: First Approval

Hannah A. Blair

Trastuzumab Rezetecan: First Approval

Sheridan M. Hoy

Elinzanetant: First Approval

Arnold Lee

Tolebrutinib: First Approval

Hannah A. Blair

Imlunestrant: First Approval

Susan J. Keam